Table 8.
BMI |
Outcome |
No. of studies | Pooled sample size |
Heterogeneity |
Overall effect |
|||
---|---|---|---|---|---|---|---|---|
T 2 | I 2 | P-value | SMD [95% CI] | P-value | ||||
BMI < 27 |
BMI |
7 |
618 |
0.83 |
94% |
<0.00001 |
-0.27 [-0.98, 0.43] |
0.45 |
|
SBP |
3 |
381 |
0.09 |
72% |
0.03 |
0.20 [-0.21, 0.60] |
0.34 |
|
DBP |
3 |
381 |
0.10 |
74% |
0.02 |
0.15 [-0.27, 0.57] |
0.48 |
|
FPG |
7 |
788 |
0.02 |
38% |
0.14 |
-0.05 [-0.24, 0.13] |
0.57 |
|
HbA1c |
6 |
720 |
0.00 |
0% |
0.43 |
0.06 [-0.09, 0.20] |
0.43 |
|
PPBS |
4 |
276 |
0.23 |
780% |
0.003 |
-0.38 [-0.91, 0.15] |
0.16 |
|
TC |
5 |
455 |
0.37 |
88% |
<0.00001 |
0.26 [-0.31, 0.84] |
0.37 |
|
HDL |
5 |
455 |
0.57 |
92% |
<0.00001 |
0.11 [-0.58, 0.81] |
0.75 |
|
LDL |
3 |
340 |
0.08 |
65% |
0.06 |
0.30 [-0.09, 0.70] |
0.14 |
|
TG |
5 |
455 |
0.13 |
72% |
0.006 |
0.33 [-0.05, 0.71] |
0.09 |
|
FINS |
5 |
352 |
0.21 |
78% |
0.001 |
-0.17 [-0.63, 0.29] |
0.47 |
BMI ≥ 27 |
BMI |
3 |
370 |
0.13 |
79% |
0.009 |
0.31 [-0.15, 0.78] |
0.18 |
|
SBP |
2 |
234 |
0.42 |
91% |
0.001 |
0.69 [-0.25, 1.63] |
0.15 |
|
DBP |
2 |
234 |
0.47 |
92% |
0.0005 |
0.63 [-0.36, 1.63] |
0.21 |
|
FPG |
2 |
300 |
0.00 |
0% |
0.82 |
0.34 [0.11, 0.57] |
0.003 |
|
HbA1c |
2 |
300 |
0.27 |
91% |
0.001 |
0.17 [-0.58, 0.93] |
0.65 |
|
PPBS |
2 |
300 |
0.01 |
29% |
0.24 |
0.09 [-0.18, 0.36] |
0.51 |
|
TC |
3 |
370 |
0.02 |
30% |
0.24 |
0.33 [0.08, 0.58] |
0.01 |
|
HDL |
3 |
370 |
0.00 |
0% |
0.71 |
0.03 [-0.18, 0.23] |
0.79 |
|
LDL |
2 |
300 |
0.00 |
6% |
0.30 |
0.32 [0.08, 0.56] |
0.008 |
|
TG |
3 |
370 |
0.00 |
4% |
0.35 |
0.15 [-0.06, 0.36] |
0.17 |
FINS | 3 | 370 | 0.76 | 95% | <0.00001 | 0.56 [-0.45, 1.57] | 0.28 |